Author:
Adi Dilare,Abuzhalihan Jialin,Wang Ying-hong,Baituola Gulinaer,Wu Yun,Xie Xiang,Fu Zhen-Yan,Yang Yi-Ning,Ma Xiang,Li Xiao-Mei,Chen Bang-dang,Liu Fen,Ma Yi-Tong
Abstract
AbstractHyperlipidemia is one of the main risk factors that contributed to atherosclerosis and coronary artery disease (CAD). In the present study, our objective was to explore whether some genetic variants of human IDOL gene were associated with hyperlipidemia among Han population in Xinjiang, China. We designed a case–control study. A total of 1,172 subjects (588 diagnosed hyperlipidemia cases and 584 healthy controls) of Chinese Han were recruited. We genotyped three SNPs (rs9370867, rs909562, and rs2072783) of IDOL gene in all subjects by using the improved multiplex ligation detection reaction (iMLDR) method. Our study demonstrated that the distribution of the genotypes, the dominant model (AA vs GG + GA), and the overdominant model (AA + GG vs GA) of the rs9370867 SNP had significant differences between the case group and controls (all P < 0.001). For rs909562 and rs2072783, the distribution of the genotypes, the recessive model (AA + GA vs GG) showed significant differences between the case subjects and controls (P = 0.002, P = 0.007 and P = 0.045, P = 0.02, respectively). After multivariate adjustment for several confounders, the rs9370867 SNP is still an independent risk factor for hyperlipidemia [odds ratio (OR) = 1.380, 95% confidence interval (CI) = 1.201–1.586, P < 0.001]. The rs9370867 of human IDOL gene was associated with hyperlipidemia in Han population.
Funder
The scientific research project of Xinjiang Medical University
National Natural Science Foundation of China-Surface Project
Tianshan cedar project-reserve candidates for scientific and technological innovation leaders
Scientific Research Program Project of Colleges and Universities in Xinjiang Uygur Autonomous region
State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund
National Natural Science Foundation of China-Major Project
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Michos Erin, D., McEvoy John, W. & Blumenthal, R. S. Lipid management for the prevention of atherosclerotic cardiovascular disease. N. Engl. J. Med. 381, 1557–1567 (2019).
2. Arnett Donna, K. et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 140, e596–e646 (2019).
3. Jennifer, A. New cholesterol guidelines personalize risk and add treatments. JAMA 321, 731–732 (2019).
4. Smith Donald, A. Review: in dyslipidemia or atherosclerotic CVD, alirocumab and evolocumab vs control each reduce MI and stroke. Ann. Intern. Med 171, JC56 (2019).
5. Fu, Z. et al. Dyslipidemia in retinal metabolic disorders. EMBO Mol. Med. 11, e10473 (2019).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献